Research Article

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection

Table 4

Sensitivity, specificity, and positive and negative predictive values of blood serum biomarkers in predicting grade prostate cancer.

According to Youden’s index90% sensitivity
Cut-offSensitivity (% (95% CI))Specificity (% (95% CI))PPV (% (95% CI))NPV (% (95% CI))Cut-offSpecificity (% (95% CI))PPV (% (95% CI))NPV (% (95% CI))

tPSA (ng/mL)4.4847.5 (31.5-63.9)68.2 (60.7-75.2)26.0 (16.5-37.6)84.7 (77.5-90.3)2.5010.6 (6.0-15.2)19.1 (13.5-24.8)81.8 (65.7-97.4)
PSAD (ng/mL/cc)0.1357.5 (40.9-73.0)77.6 (70.1-83.7)37.7 (25.6-51.0)88.6 (82.4-93.2)0.045.3 (2.5-9.8)19.1 (13.9-25.3)81.8 (48.2-97.7)
fPSA (ng/mL)0.7377.5 (61.6-89.2)34.1 (27.0-41.8)21.7 (15.2-29.3)86.6 (76.0-93.7)0.296.5 (2.8-10.2)18.5 (13.0-23.9)73.3 (51.0-95.7)
%fPSA11.30-11.6957.5 (40.9-73.0)78.8 (71.9-84.7)39.0 (26.6-52.6)88.7 (82.6-93.3)7.004.7 (1.5-7.9)17.8 (12.4-23.1)61.5 (35.1-88.0)
p2PSA (pg/mL)26.11-30.297.5 (1.6-20.4)96.5 (92.5-98.7)33.3 (7.5-70.1)81.6 (75.5-86.7)6.218.8 (4.6-13.1)18.8 (13.3-24.4)78.9 (60.6-97.3)
%p2PSA1.8885.0 (70.2-94.3)47.6 (39.9-55.4)27.6 (20.0-36.4)93.1 (85.6-97.4)1.6534.1 (27.0-41.2)24.3 (17.7-32.1)93.5 (87.4-100.0)
phi44.7175.0 (58.8-87.3)72.4 (65.0-78.9)39.0 (28.1-50.8)92.5 (86.6-96.3)33.2034.7 (27.6-41.9)24.5 (17.54-31.4)93.7 (87.6-100.0)
PHID1.0475.0 (58.8-87.3)66.5 (58.8-73.5)34.5 (24.6-45.4)91.9 (85.6-96.0)0.6334.1 (27.0-41.8)24.3 (17.4-31.2)93.5 (87.4-98.2)

Abbreviations: CI: confidence interval; fPSA: free prostate-specific antigen; ISUP: International Society of Urological Pathology; NPV: negative predictive value; PPV: positive predictive value; PSAD: prostate-specific antigen density; phi: Prostate Health Index; tPSA: total PSA; %fPSA: free to total PSA ratio; %p2PSA: p2PSA to fPSA ratio.